Table: Taiko Pharmaceutical -9-MTH group results

Taiko Pharmaceutical

12/02/2016 06:00

Feb 12 (Reuters)-  
             Taiko Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Dec 31, 2015        Dec 31, 2014     Mar 31, 2016  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               6.10                7.21             9.20      
                   (-15.4 pct)         (-8.1 pct)       (+2.5 pct)   
  Operating           1.28                2.53             1.55      
                   (-49.3 pct)         (-3.4 pct)       (-39.4 pct)  
  Recurring           1.32                2.74             1.45      
                   (-51.9 pct)         (+1.0 pct)       (-47.8 pct)  
  Net                774 mln              1.80             1.00      
                   (-57.1 pct)         (-5.9 pct)       (-43.5 pct)  
  EPS               60.21 yen          141.73 yen        78.24 yen   
  EPS Diluted       58.79 yen          138.42 yen                    
  Ann Div                               25.00 yen        15.00 yen   
  -Q2 div              NIL                 NIL                       
  -Q4 div                               25.00 yen        15.00 yen   
   
  NOTE - Taiko Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T 
  ((Tokyo Headline News Desk +813 6441 1812))